Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: Brain magnetic resonance imaging features and evolution

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Manara, Renzo ^a   Rampazzo, Angelica ^b   Cananzi, Mara ^b   Salviati, Leonardo ^b   Mardari, Rodica ^a   Drigo, Paola ^b   Tomanin, Rosella ^b   Gasparotto, Nicoletta ^b   Priante, Elena ^b   Scarpa, Maurizio ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPHY; BRAIN; CHILD; COGNITION; COGNITION DISORDERS; DISEASE PROGRESSION; ENZYME REPLACEMENT THERAPY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; IDURONATE SULFATASE; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MUCOPOLYSACCHARIDOSIS II; MUTATION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 79956269619     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9023-8     Document Type: Article

References (29)

1. Aleu FP, Terry RD, Zellweger H (1965) Electron microscopy of two cerebral biopsies in gargoylism. J Neuropathol Exp Neurol 24: 304-317
2. Broadhead DM, Kirk JM, Burt AJ et al (1986) Full expression of Hunter's disease in a female with an X-chromosome deletion leading to non-random inactivation. Clin Genet 30: 392-398
3. Bunge S, Rathmann M, Steglich C et al (1998) Homologous nonallelic recombinations between the iduronate-sulfatase gene and pseudogene cause various intragenic deletions and inversions in patients with mucopolysaccharidosis type II. Eur J Hum Genet 6: 492-500
4. Clarke JT, Greer WL, Strasberg PM et al (1991) Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl. Am J Hum Genet 49: 289-297
5. Clarke JT, Willard HF, Teshima I et al (1990) Hunter disease (mucopolysaccharidosis type II) in a karyotypically normal girl. Clin Genet 37: 355-362
6. Clarke JT, Wilson PJ, Morris CP et al (1992) Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet 51: 316-322
7. Cudry S, Tigaud I, Froissart R et al (2000) MPS-II in females: molecular basis of two different cases. J Med Genet 272: 29-37
8. Finn CT, Vedolin L, Schwartz IV et al (2008) Magnetic resonance imaging findings in Hunter syndrome. Acta Paediatr Suppl 97: 61-68
9. Gabrielli O, Polonara G, Regnicolo L et al (2004) Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am J Med Genet 15: 224-231
10. Gort L, Chabás A, Coll MJ (1999) A new polymorphism in the iduronate-2-sulphatase gene. Implications for the diagnosis of Hunter disease. J Inherit Metab Dis 22: 844
11. Hers HG, van Hoof F (1969) Lysosomes and mucopolysaccharidoses. Biochem J 115: 34P-36P
12. Lee C, Dineen TE, Brack M et al (1993) The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR Am J Neuro-radiol 14: 1285-1292
13. Martin R, Beck M, Eng C et al (2008) Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 121: 377-386
14. Moreira da Silva I, Froissart R, Marques dos Santos H et al (2001) Molecular basis of mucopolysaccharidosis type II in Portugal: identification of four novel mutations. Clin Genet 60: 316-318
15. Mossman J, Blunt S, Stephens R et al (1983) Hunter's disease in a girl: association with X:5 chromosomal translocation disrupting the Hunter gene. Arch Dis Child 58: 911-915
16. Neufeld FN, Muenzer J (2001) The mucopolysaccharidosis. In: Scriver CR, Beaudet AL, Valle D, Sly WS (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 3421-3452
17. Schwartz IV, Ribeiro MG, Mota JG et al (2007) A clinical study of 77 patients with mucopolysaccharidosis type II. Acta Paediatr Suppl 96: 63-70
18. Seto T, Kono K, Morimoto K et al (2001) Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 50: 79-92
19. Shinomiya N, Nagayama T, Fujioka Y et al (1996) MRI in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neurora-diology 38: 483-485
20. Sleddens HF, Oostra BA, Brinkmann AO et al (1993) Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet 2: 493
21. Sukegawa K, Song XQ, Masuno M et al (1997) Hunter disease in a girl caused by R468Q mutation in the iduronate-2-sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele. Hum Mut 10: 361-367
22. Sukegawa K, Matsuzaki T, Fukuda S et al (1998) Brother/sister siblings affected with Hunter disease: evidence for skewed X chromosome inactivation. Clin Genet 53: 96-101
23. Timms KM, Bondeson ML, Ansari-Lari MA et al (1997) Molecular and phenotypic variation in patients with severe Hunter syndrome. Hum Mol Genet 6: 479-486
24. Tuschl K, Gal A, Paschke E et al (2005) Mucopolysaccharidosis type II in females: case report and review of literature. Pediatr Neurol 32: 270-272
25. Vallance HD, Bernard L, Rashed M et al (1999) Identification of 6 new mutations in the iduronate sulfatase gene. Hum Mutat 13: 338
26. Vedolin L, Schwartz IV, Komlos M et al (2007a) Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 69: 917-924
27. Vedolin L, Schwartz IV, Komlos M et al (2007b) Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. Am J Neuroradiol 28: 1029-1033
28. Winchester B, Young E, Geddes S et al (1992) Female twin with Hunter disease due to non random inactivation of the X-chromosome: a consequence of twinning. Am J Med Genet 44: 834-838
29. Young ID, Harper PS, Newcombe RG et al (1982) A clinical and genetic study of Hunter's syndrome 2: differences between the mild and severe forms. J Med Genet 19: 408-411